Medtronic has announced the launch of the Avalus Ultra surgical aortic tissue va...
The American Association for Thoracic Surgery (AATS) and the Cardiovascular Rese...
Biotronik has announced a multinational distribution partnership with Texray...
Concept Medical has announced the commencement of its investigational device exe...
“Unfortunately, we are doing worse for our patients today,” were the soberin...
Foldax has announced that its Tria valves have surpassed 200 patient life ye...
FastWave Medical has announced the issuance of its fourth utility patent by the ...
Simpson Interventions has announced that its Acolyte image-guided crossing and r...
Caranx Medical has announced the successful completion of a robotic transcathete...
Cardiawave SA has appointed of Olivier Pierron as its new chief executive office...
Vivasure Medical has announced the treatment of the first large bore venous pati...
Transverse Medical, developer of the Point-Guard cerebral embolic protection dev...
Acarix has announced the initiation of a US-based clinical study to collect ...
Use of the Impella CP (Abiomed) micro-axial flow pump in the treatment of pa...
People with chronic chest pain who received a coronary sinus reducer (CSR, S...
Medtronic has unveiled top line findings of a survey on women's perceptions ...
Results of the SMART trial, comparing the use of two widely deployed transca...
Patients with heart failure who had an interatrial shunt inserted between th...
Johnson & Johnson is to acquire Shockwave Medical, it has been announced tod...
Automated external defibrillators (AEDs) were used in in 13 of nearly 1,800 ...
Around 10% of all deaths following percutaneous coronary intervention (PCI) are ...
GE HealthCare has announced the launch of Caption AI artificial intelligence...
TRiCares has announced the appointment of Ahmed Elmouelhi as president &...
Michael Reardon and Lars Søndergaard pay tribute to the life and legacy of A...
Debates will shed new light on controversies in the treatment of aortic dise...
Abbott has announced that the US Food and Drug Administration (FDA) has approved...
Protembis has announced the enrolment of the first patient in the PROTEMBO inves...
Merck has announced the US Food and Drug Administration (FDA) has approved sotat...
egnite, a digital health company specialising in cardiovascular care, has announ...
Medtronic has announced that the US Food and Drug Administration (FDA) has a...
HeartFlow has announced the launch of the DECIDE registry, the largest prospecti...
Abbott has announced that the first patient has been enrolled in the ENVISION in...
The use of a radiation shield system—Protego (Image Diagnostics)—could marke...
The first US Food and Drug Administration (FDA) approval of a drug-coated ba...
A company specialising in less invasive structural heart procedures has said tha...
BioCardia and StemCardia has a long-term partnership to advance StemCardia’s inv...
Medtronic has received a license from Health Canada for its Symplicity Spyral mu...
ConKay Medical Systems, a medtech start-up company developing a device for treat...
Best Cardiovascular Product Launch– Siemens Healthineers: ARTIS Family
...
A founding father of transcatheter aortic valve implantation (TAVI), profess...
Medtronic has announced two late-breaking data presentations on four-year ou...
Cardiothoracic surgeon Gilbert Tang (Mount Sinai Health System, New York, US...
This educational supplement, sponsored by Medtronic, explores the latest thinkin...
This advertorial is sponsored by JenaValve
Transcatheter aortic valve imp...
HeartFlow has announced that 10-year follow-up data from its DISCOVER-FLOW s...
SS Innovations International has announced that surgeons have performed the worl...
Saranas has announced results of SAFE-MCS, a multicentre clinical study evaluati...
Results from two large, real-world studies assessing outcomes for patients u...
The US Food and Drug Administration (FDA) has approved an additional indicat...
PulseCath has announced the transition from CE marking to EU Medical Device Regu...
Cleerly has been granted breakthrough device designation by the US Food and Drug...
Six-month results from the PROACTIVE-HF pivotal trial, evaluating the Cordel...
BioCardia has announced interim results from the phase III randomised controlled...
FastWave Medical has announced the issuance of its third utility patent by the U...
Hawthorne Effect, a specialist in technology-enabled mobile clinical researc...
Boston Scientific has announced that it has received US Food and Drug Administra...
New guidelines from the European Association for Cardio-Thoracic Surgery (EA...
Royal Philips has announced the launch of their image-guided therapy mobile ...
FIRE1 today announced that it has completed patient enrolment in the US early fe...
VahatiCor has announced the treatment of the first patient with the A-Flux R...
Like London buses, interventionalists have had a long wait for the US Food a...
Bernardo Cortese (Fondazione Ricerca e Innovazione Cardiovascolare, Lodi, Italy ...
Attaulah Khan Niazi (King Edward Medical University, Lahore, Pakistan) documents...
Foldax has announced a manufacturing agreement with Dolphin Life Science Ind...
Biosense Webster has announced the commencement of patient cases with the invest...
Ismail El-Hamamsy, director of aortic surgery for the Mount Sinai Health Sys...
Laplace Interventional has announced the successful completion of its first-...
Philips' LumiGuide ‘human GPS’ technology is now available to specialised ho...
In this issue:
New data point to shift towards TAVI in patients aged under ...
In this issue:
New data point to shift towards TAVI in patients aged under ...
NeoChord has appointed Todd Berg as chief executive officer to oversee clinical...
For Ajay Kirtane (Columbia University Irving Medical Center/NewYork-Presbyterian...
Two meta-analyses comparing the use of intravascular imaging to angiography ...
BiVACOR, a clinical-stage medical device company, has announced that US$13 milli...
Reprieve Cardiovascular, a development stage company focused on pioneering an au...
Transcatheter aortic valve implantation (TAVI) procedures were more acutely ...
Alain Cribier, the pioneering cardiologist who performed the world’s first t...
The Circulatory System Devices Panel of the Medical Devices Advisory Committee f...
Biotronik has announced the CE approval and launch of the Freesolve resorbable m...
Investigators behind the largest randomised trial to date to assess the use ...
AorticLab has announced CE mark certification for the FLOWer transcatether embol...
Biotronik has launched the Micro Rx novel rapid exchange microcatheter to enhanc...
The REDUCED-1 study, a US Food and Drug Administration (FDA) investigational dev...
Venus Medtech has announced that the VenusP-Valve transcatheter pulmonic valve r...
Genesis MedTech has announced the completion of enrolment in its US early feasib...
A study of more than one million patients undergoing isolated coronary arter...
Edwards Lifesciences has announced that its Evoque tricuspid valve replaceme...
Data from the first US comprehensive single-centre experience at St Bernard’s Me...
Two specialist heart teams are vying to win the Heart Team of the Year Award at ...
A newly published Society for Cardiovascular Angiography and Interventions (...
Royal Philips has received US Food and Drug Administration (FDA) 510(k) clearanc...
Endospan shared 30-day results from the first 22 patients enrolled in the TR...
Jennifer C Romano has been named president of the Society of Thoracic Surgeo...
Research presented at the 60th annual meeting of the Society of Thoracic Sur...
The results of a propensity-matched analysis of all patients undergoing mitral v...
CroíValve has announced the initiation of its early feasibility study (EFS) for ...
Medtronic recently announced that Simona Zannetti has been appointed as the ...
PlaqueTec, a company identifying endotype-specific biomarkers to advance precisi...
Anteris Technologies has announced the successful completion of three new valve-...
Pi-Cardia has received breakthrough device designation from the US Food and Drug...
The full shortlist for the inaugural Global Cardiovascular Awards—which will rec...
Novostia has announced the successful first-in-human implantation of its Triflo ...
An analysis of data from the SPYRAL HTN-ON MED trial of the Symplicity Spyra...
FastWave Medical has announced the successful completion of enrolment for it...
Allowing patients to eat before elective cardiac catheterisation posed no safety...
Cardiac Dimensions, a developer of invasive treatment modalities to address ...
Penumbra has secured CE mark for its Indigo system CAT RX designed to address th...
Occlutech has announced that the US Food and Drug Administration (FDA) has appro...
Realize Medical has announced that its virtual reality (VR) software for surgica...
Orchestra BioMed Holdings has announced the first patient was randomised in the ...
Endovascular Engineering (E2) has announced US Food and Drug Administration (FDA...
People taking medical cannabis for chronic pain have a slightly increased ri...
Cook Medical has announced that its Slip-Cath Beacon Tip hydrophilic selecti...
Proceedings from an expert consensus roundtable that discussed the benefits ...
GE HealthCare has entered into an agreement to acquire MIM Software, a provider ...
Robocath has announced the granting of a marketing authorisation to distribute i...
Endotronix has submitted a premarket approval (PMA) application for its Cord...
Eisenhower Health (Rancho Mirage, USA) is the first hospital in the USA to b...
TRiCares SAS has announced the successful implantation of its Topaz transfemoral...
Laguna Tech USA has announced that a record number five patients were successful...
HeartFlow, a developer of non-invasive artificial intelligence (AI) precisio...
Pulse Biosciences has filed a premarket notification 510(k) to the US Food and D...
Norway-based CardioMech AS, a medical device company developing a transfemor...
Gore has announced the first patient implantation of the Gore ascending stent gr...
Which stories, features and interviews captured the attention of the cardiovascu...
CardioRenal and CHU Grenoble Alpes have announced an innovation that allows chro...
LUMA Vision, developer of a novel four-dimensional (4D) cardiac imaging and ...
Thubrikar Aortic Valve has received authorisation from the Competent Authority o...
Microbot Medical, developer of the Liberty endovascular robotic surgical system,...
Results of the National Cardiogenic Shock Initiative—a single-arm multicentre st...
iVascular has announced the initiation of its first randomised trial of an abbre...
Robocath has announced a first-in-human robotic coronary angioplasty performed a...
Vivasure Medical has announced the first patient treated with PerQseal Elite, th...
Haemonetics Corporation has completed its acquisition of OpSens, the company ann...
A public-private partnership, involving input from clinical and industry partner...
Cardiovascular diseases, including ischaemic heart disease, stroke, heart failur...
Pi-Cardia has appointed Gary Gratson to lead commercial operations for Short...
Patients who received warfarin after bioprosthetic aortic valve replacement had ...
The cardiologist and researcher, Harlan M Krumholz (Yale School of Medicine,...
Details of the first pivotal trial assessing the use of a dedicated leaflet ...
Healthcare 21 (HC21) has gained national reimbursement for Catheter Precision’s ...
Kaneka Corporation has acquired all shares of Japan Medical Device Technology Co...
Investigators behind the BIOPATTERN trial hope that their work will shape th...
Carmat has opened a second production facility in Bois-d'Arcy.
Works on the s...
Medtronic has announced the launch of its Penditure left atrial appendage (L...
Procyrion has announced the enrolment of the first patients in the company’s...
Johnson & Johnson MedTech has announced the completion of the acquisition of...
ReValve Solutions has announced the successful first-in-human use of its Palmett...
The US Food and Drug Administration (FDA) has given the green light for commence...
PlaqueTec has received approval from UK’s Medicines and Healthcare products ...
Inari Medical has announced the first patient enrolment in PEERLESS II. This p...
Foldax has announced completion of enrolment in the Indian clinical trial of...
Abiomed has announced that the first patient in the world has been enrolled in t...
The occurrence of atrial fibrillation (AF) after mitral valve surgery may be mor...
A historic underrepresentation of women in clinical trials for coronary arte...
“It has been a good day for TAVI ,” commented Raj Makkar (Cedars-Sinai, Los ...
Death rates after major surgery are similar regardless of whether a male or fema...
A comparison of two latest-generation self-expanding and balloon-expandable ...
A novel risk score derived from artificial intelligence (AI) may be more eff...
The approval of two renal denervation devices by the US Food and Drug Administra...
Supira Medical announced today that it has received US Food and Drug Adminis...
Global Heart Hub, an international alliance of heart patient organisations, has ...
Medtronic has announced approval from the US Food and Drug Administration (FDA) ...
JenaValve Technology has announced that it will join the American Society of Ech...
This advertorial is sponsored by Medtronic
With transcatheter aortic valv...
Inspired by a passion for nature, Jolanda Kluin began her career in medicine in ...
In this issue:
Low-risk TAVI trials spark optimism, but surgical societies ...
In this issue:
Low-risk TAVI trials spark optimism, but surgical societies ...
Abbott has announced new late-breaking data that show advanced heart failure...
Teleflex has announced the first patient enrolment in a clinical registry that i...
Cleerly has announced the TRANSFORM trial a randomised trial that aims to en...
New analyses from the VOYAGER PAD clinical trial in both high-risk and fragi...
Filterlex Medical has announced the publication of a first-in-human (FIH) st...
Enhanced external counterpulsation (EECP, Flow Therapy), a non-invasive trea...
Vivasure Medical has enrolled the 100th patient in its PATCH clinical study,...
Results from first-in-human (FIH) clinical studies on 40 patients suffering from...
CoreMedic has announced the first successful application of its ChordArt transca...
RCE Technologies, the developer of a non-invasive, instant measurement of ca...
Results of the SELECT clinical trial, presented at the American Heart Associatio...
Xenter unveiled its dual sensor investigational guidewire for transcatheter aort...
Percutaneous coronary intervention (PCI) relieves stable chest pain and impr...
A new study published in BJS Open has found that revascularisation treatment...
The aortic programme at the 2024 Charing Cross (CX) Symposium (23–25 April, Lond...
Medinbox has launched its latest product suites to enhance live collaboratio...
Cordis has announced that its board of directors has appointed Scott Drake a...
Recor Medical has become the first company in the USA to have a device-based...
Conformal Medical has announced positive one-year results from the company's...
Patients with atrial fibrillation (AF) undergoing a transcatheter aortic val...
Data from the REAL-PE study, presented at TCT 2023 (23–26 October, San Franc...
Penumbra, a global healthcare company focused on innovative therapies, annou...
Surmodics has announced the commercial launch of its most advanced hydrophilic m...
Endovascular Engineering (E2) has announced positive initial results from its EN...
Cordis has announced enrolment of the first patient in its SELUTION4DeNovo IDE t...
New research from the FLASH registry shines a light on the effectiveness of ...
Positive results from the ALIGN AR pivotal trial, investigating the use of t...
Laguna Tech USA has announced that the first-in-human clinical case was complete...
Edwards Lifesciences has received CE mark for the Mitris Resilia tissue valve re...
Analysis of health status and quality of life data from the TRILUMINATE Pivo...
A randomised trial comparing transcatheter tricuspid valve replacement (TTVR...
The first US randomised trial investigating the safety and efficacy on the u...
Five-year data from the PARTNER 3 trial, which randomised low surgical risk ...
Results of the LIFE-BTK randomised controlled trial have just been presented...
HeartPoint Global was named winner in the Shark Tank Innovation Competition at t...
Medinol today announced US Food and Drug Administration (FDA) approval for t...
At four years of follow-up, patients with severe aortic stenosis at low risk...
Data from a patient-level meta-analysis—a factor in the US Food and Drug Adm...
GE HealthCare has announced US Food and Drug Administration (FDA) 510(k) clearan...
Patients have passed through the multi-month enhanced screening process and ...
New research examining the safety and efficacy of using radial access for pe...
Researchers behind a trial to quantify the true prevalence of valvular heart dis...
Medtronic has received CE mark for the Evolut FX transcatheter aortic valve impl...
A population-based cohort study of patients treated in the Austrian healthca...
OpSens has entered into a definitive arrangement agreement with Haemonetics Corp...
FEops has entered into a partnership with ConcertAI’s TeraRecon for the comm...
Endotronix has received investigational device exemption (IDE) approval from...
Roger Malcolm Greenhalgh, the surgeon internationally renowned for his unpar...
Data from the On-X aortic heart valve low INR post-market study, presented d...
Elixir Medical has announced submission to Japan’s Pharmaceutical and Medica...
Artivion has announced presentation of interim results from the Ascyrus medical ...
Ongoing statin treatment may be beneficial for patients after isolated surgi...
A new study has shed fresh light on the potential connection between pre-existin...
Anumana has announced US Food and Drug Administration (FDA) 510(k) clearance for...
MedAlliance has been acquired by Cordis for a 2022 investment of US$35 million a...
EnCompass Technologies has announced that the US Food and Drug Administration (F...
Boston Scientific has announced US Food Administration (FDA) clearance of the AV...
Surgeons at the University of Maryland Medical Center (UMMC, Baltimore, USA) hav...
Inorganic nitrate reduces contrast-induced nephropathy (CIN), improves renal out...
Shockwave Medical has announced that Nick West has joined the company in the...
As one of the UK’s leaders in interventional cardiology, David Hildick-Smith (Un...
In this issue:
Societies weigh in on renal denervation as US Food and Drug ...
In this issue:
Societies weigh in on renal denervation as US Food and Drug ...
Pi-Cardia has announced the successful completion of its ShortCut pivotal study ...
This advertorial is sponsored by Medtronic
Hypertension is a leading cause of...
A survey of cardiac surgeons and interventional cardiologists from 26 European n...
SpectraWAVE has announced US Food and Drug Administration (FDA) 510(k) clearance...
Saranas has completed enrolment in SAFE-MCS, a multicentre, single arm, open-lab...
MedAlliance has announced enrolment of over 1,660 patients in its SELUTION DeNov...
FastWave Medical recently announced the swift closure of an oversubscribed...
HighLife SAS has announced the introduction of a new valve size in its clinical ...
Ten-year data from the NOTION trial—the longest-running clinical trial to da...
Boston Scientific has received US Food and Drug Administration (FDA) approva...
The first patient has been enrolled in a UK study of large vessel de novo corona...
The first-in-man (FIM) use of the NyokAssist (magAssist) percutaneous ventri...
A study assessing the impact of the addition of adding coronary computed tom...
One-year-data from the BIOFLOW-DAPT trial demonstrated non-inferiority and a goo...
Protembis has announced the appointment of J Mocco (Icahn School of Medicine at ...
Radiaction Medical has raised US$12.6 million in Series C2 funding led by US pri...
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has desi...
Extended P2Y12 inhibitor monotherapy beyond 12 months after percutaneous corona...
A joint review of evidence into the treatment of patients at low surgical-risk w...
Early extracorporeal life support (ECLS) does not improve survival in patien...
Results of the first randomised trial comparing pulsed field ablation (PFA) ...
GE Healthcare has announced the launch of two new tools for the cardiology m...
Data from three randomised trials and a meta-analysis presented at the Europ...
The Society for Cardiovascular Angiography & Interventions’ (SCAI’s) po...
Siemens Healthineers has unveiled the Acuson Origin, a dedicated cardiovascular ...
The Society for Cardiovascular Angiography & Interventions (SCAI) has welcom...
A simple blood test may predict the risk of progressive kidney and heart disease...
The US Food and Drug Administration (FDA) Circulatory Systems Devices Panel ...
The heart teams at the Piedmont Heart Institute (Atlanta, USA) and the Unive...
The US Food and Drug Administration (FDA) Circulatory Systems Devices Panel of t...
Myocardial infarction (MI) patients who do not take daily aspirin have an elevat...
Enrolment has been completed in the US Food and Drug Administration (FDA)-approv...
Advanced NanoTherapies—ANT—has announced the completion of a US$4million Ser...
The Society for Cardiovascular Angiography & Interventions (SCAI) has releas...
The British Heart Foundation (BHF) has appointed research leader and NHS con...
Latest research in the field of renal denervation has prompted its inclusion...
AstraZeneca’s Forxiga (dapagliflozin) has been approved in China for use in adul...
Heart failure start-up Acorai has announced the initiation of a global clini...
An artificial intelligence (AI) model may be more efficient at detecting signatu...
Research published in the journal Circulation: Cardiovascular Quality and Ou...
A new digital tool launched by the Society of Thoracic Surgeons (STS) draws ...
Viz.ai has received a de novo approval by the US Food and Drug Administratio...
CytoSorbents has announced the completion of the pivotal STAR-T (Safe and Timely...
Xeltis has announced the closing of an additional €12.5 million in funding from ...
Orchestra BioMed Holdings has been granted US Food and Drug Administration (FDA)...
Anteris Technologies has reported that its DurAVR biomimetic, single-piece t...
Ilika and Cirtec Medical have announced that they have signed a 10-year manufact...
Venus Medtech has announced US Food and Drug Administration (FDA) Investigationa...
Canon Medical has introduced its Alphenix / Evolve Edition angiography system fo...
Ian Meredith is a well-known figure within the field of interventional cardi...
Hitting the headlines in July were new European guidelines on the treatment ...
Shockwave Medical has announced that as part of the Fiscal Year 2024 Medicare Ho...
The World Health Organization (WHO) has included a cardiovascular polypill—an al...
Peijia Medical has announced that the first Chinese patient has been enrolled in...
Laplace Interventional, a medical device company developing a transcatheter ...
Foldax has announced that the first 30 patients have been treated outside of...
Genesis MedTech has announced that its J-Valve transfemoral (TF) system has been...
Applying artificial intelligence (AI) to a single apical four chamber (A4C) ...
Respective results from the REVEALPLAQUE, DECODE, and SMART-CT were presente...
Anteris Technologies has announced that the DurAVR transcatheter heart valve...
RapidAI today announced US$75 million in Series C funding led by Vista Credit Pa...
CardioPrecision, a developer of less invasive treatment solutions for structural...
Innovation is a part of the DNA of cardiothoracic surgery, Friedhelm Beyersd...
HeartBeam, developer of a 3D-vector electrocardiogram (VECG) platform, has a...
Researchers will carry out the first clinical trial focusing on women and minori...
The combination of soaring heat and fine particulate pollution may double the ri...
Entries are now open for the inaugural edition of the Global Cardiovascular Awar...
Onecrea Medical has announced the success of the first-in-human implants of its ...
PECA Labs has added Jeffrey P Carpenter, Jeffrey O’Donnell Sr and Samuel E Navar...
Interventional cardiologists need to have a range of approaches and devices i...
The president of the Society for Cardiovascular Angiography & Interventi...
Avertix Medical—formerly known as Angel Medical Systems—has announced that I...
The TIMELY consortium announced today the enrolment of the first patient in the ...
ReCor Medical and its parent company Otsuka Medical Devices have welcomed th...
Elixir Medical has announced enrolment completion in INFINITY-SWEDEHEART, a ...
A dedicated, prospective randomised controlled trial (RCT) investigating the saf...
Citizens of Europe at risk for heart attacks, stroke and chronic kidney disease ...
Results of a stent-level analysis from the HOST-IDEA study, which compared t...
In a major Swedish study, researchers have discovered a link between the lev...
The release of a letter from the US Food and Drug Administration (FDA) concernin...
Following yesterday's news that the US Food and Drug Administration (FDA) has ch...
Verve Medical has received approval from the US Food and Drug Administration (FD...
FIRE1 has announced that the first US patients have been successfully implanted ...
In a letter to healthcare providers dated 11 July 2023, the US Food and Drug...
Sequana Medical NV has announced that the first patient has been enrolled in the...
Alvimedica has announced the launch of the Alvision Kaplan curves radial portfol...
Physicians at the James Cook University Hospital (Middlesbrough, UK) have pe...
Researchers have developed a soft, fully bioresorbable, transparent microelectro...
Abbott has announced that the US Food and Drug Administration (FDA) has approved...
EBC MAIN investigator David Hildick-Smith (Brighton, UK) delivers key messag...
In the wake of the release of update guidelines from the European Hypertension S...
The combined presence of chronic kidney disease and diabetes among women undergo...
Researchers have found that the minimum level of oxygen delivery during cardiopu...
Translumina has announced the acquisition of Blue Medical Devices, a Wellinq...
CathWorks has announced that the first patient has been enrolled in the Adva...
Patients who feel low when having a cardiac device implanted are more likely...
New and expanded guidelines from the European Society of Hypertension (ESH) conc...
Anumana has received breakthrough device designation from the US Food and Drug A...
Vygon, a specialist in the design, manufacturing and marketing of medical device...
A new study from Keck Medicine at the University of Southern California (USC...
The US Food and Drug Administration (FDA) has approved the use of iTFlow in bloo...
CorWave has raised €61 million to fund its first industrial deployment and entry...
egnite and JenaValve Technology have announced a strategic partnership aimed to ...
Nearly one-third of patients with an implanted device to prevent sudden deat...
PECA Labs has announced the successful first-in-human implant of the MASA valve,...
In order to avoid coronary obstruction—a rare but “nasty” complication of tr...
Teleflex has received US Food and Drug Administration (FDA) clearance for the Wa...
Patients with ST-elevation myocardial infarction (STEMI) occurring during th...
Results of the first study of a first-generation drug-coated balloon (DCB) w...
Dasi Simulations has announced it has received US Food and Drug Administration (...
The European Society of Cardiology (ESC) has announced the appointment of Je...
Translumina has announced the acquisition of Munich-based Lamed GmbH, which ...
The US Food and Drug Administration (FDA) has released draft guidance with u...
While the exact location of atherosclerotic plaque ruptures—a common cause of my...
Defibrillators are being used in just one in 10 cardiac arrests where they are a...
Lars Søndergaard has left his role as professor of cardiology at Rigshospitalet,...
Conformal Medical has announced the successful completion of its series D fu...
EnCompass Technologies has announced its novel F2 cerebral embolic filter was us...
Medtronic has announced that Ken Washington has been appointed chief technology ...
Valve Medical, a wholly owned subsidiary of Medinol Ltd, has announced the first...
Discharging patients early after transcatheter aortic valve implantation (TA...
This advertorial is sponsored by Boston Scientific
Stroke—particularly disabl...
New data presented from an investigator-sponsored European trial found managing ...
Thirona recently announced its new artificial intelligence (AI)-based algorithm ...
Cora Therapeutics has announced the presentation of the results of a clinica...
An international clinical trial presented today at the European Stroke Organ...
Implementation of a dedicated training programme allowed hospitals to incre...
Enrolment in the EURO SHOCK trial was curtailed due to the COVID-19 pandemi...
Ticagrelor monotherapy after three months of ticagrelor plus aspirin was ass...
Preliminary results from the BIO-LIBRA study, assessing the outcomes of devi...
Results from a pivotal clinical trial found a leadless pacemaker can deliver...
Inventor of the Valsalva aortic graft Ruggero De Paulis (European Hospital Unica...
In this issue:
A new era for intracoronary imaging
Top trials from ACC 2...
A large registry study of patients undergoing transcatheter edge-to-edge rep...
A novel artificial intelligence (AI) model correctly identified patients at near...
Analysis of the Global SYMPLICITY registry DEFINE (GSR DEFINE), presented at...
Paolo Contessotto (National University of Ireland Galway, Galway, Ireland) outli...
Bentley has announced the US launch of its BeBack crossing catheter, which is de...
A randomised controlled trial comparing the safety of distal versus proximal rad...
Six-month outcomes from FLASH registry have shown that patients with pulmonary e...
Medtronic has announced two-year results for its Harmony transcatheter pulmonary...
Results of the first-in-human study BIOMAG-I study, assessing Biotronik’s la...
Analysis from The North American COVID-19 STEMI (NACMI) registry, presented ...
The Society for Cardiovascular Angiography & Interventions (SCAI) has na...
Elixir Medical has announced that the BIOADAPTOR RCT trial of the company’s ...
New data from the Benchmark Registry, a study of a streamlined transcatheter aor...
A process of flushing prosthetic valves using carbon dioxide (CO2) prior to ...
First-generation bioresorbable vascular scaffolds (BVS) may be just as effec...
A machine learning-based model which uses electronic health record (EHR) dat...
Edwards Lifesciences has announced new data from the COMMENCE aortic trial, ...
A real-world comparison of two techniques aimed at reducing the risk of coro...
Operators performing percutaneous coronary intervention (PCI) in bifurcation...
The use of an image-guidance system that overlays angiographic images on liv...
In this issue:
A new era for intracoronary imaging
Top trials from ACC 2...
Robocath has announced the launch of its latest robotic platform—the R-One+.
...
Shockwave Medical has announced the full commercial availability of the Shockwav...
Foldax has announced that it has executed an agreement with Australia’s nati...
OpSens has announced the inclusion of SavvyWire in the COMPLETE TAVR clinical st...
In a recent study, researchers determined that derivatives of natural emulsi...
Postmenopausal women with clogged arteries are at higher risk of heart attac...
This educational supplement, sponsored by Shockwave Medical, gains fresh perspec...
How has the new Shockwave C2+ catheter changed the treatment of calcified co...
Calcified nodules are frequently identified among coronary artery lesions an...
Tom Johnson (University Hospitals Bristol & Weston NHS Foundation Trust,...
Akura Medical announced today it has initiated its first-in-human clinical study...
This advertorial is sponsored by Medtronic
New data offer greater perspec...
This advertorial is sponsored by B Braun Melsungen AG
“The evolution of PCI ...
A recent study has found deep neural networks (DDNs)—a category of artificia...
AstraZeneca’s Farxiga (dapagliflozin) has been approved in the USA to reduce the...
Emboline has announced that the first patient has been treated in the Protect th...
Judges of the CX 2023 Dragon’s Den-style contest — the finale of the Day 3 C...
News highlights this April were brought by Podium First data from the BASIL-...
Vivasure Medical has announced it has enrolled the first patients in the com...
The US Food and Drug Administration (FDA) has granted the third investigational ...
Research has highlighted significant regional variations in the availability...
Ultromics has been granted US Food and Drug Administration (FDA) breakthrough de...
Statin treatment after aortic repair is associated with improved long-term s...
A question from Manj Gohel (Cambridge University Hospitals NHS Foundation Trust,...
Cardiac Dimensions has announced that its Carillon mitral contour system, fo...
Cardialysis, the 40-year old cardiovascular research organisation, based in ...
Pie Medical Imaging has received NINSHO Medical Device Certification for CAAS Qa...
Effective management of depression through psychological therapy is associated w...
Adept Medical has launched the Adducted Arm Scoop—an improved solution for s...
The first transcatheter tricuspid valve replacement procedure in the USA usi...
Deaths from cardiovascular disease are elevated on polluted days and for two day...
Shockwave Medical has announced the completion of its previously announced a...
OpSens has announced the successful completion of enrolment in the SAFE–TAVI cli...
The news agenda in March was dominated by late-breaking data from the American C...
AVS, an early-stage medical device company focused on safely and effectively...
New research will investigate how stretching and blood flow can inhibit or e...
Medtronic has announced the launch of MRI Care Pathway, a new system designed to...
Endotronix has announced its PROACTIVE-HF pivotal study has successfully com...
Wearable devices such as smart watches could be used to detect a higher risk of ...
The UK’s first remotely-supported transcatheter aortic valve implantation (TAVI)...
Cardiovascular Systems has announced the complete enrolment of its 2,000-pat...
The Society for Cardiovascular Angiography & Interventions (SCAI) and th...
Abbott has announced that the US Food and Drug Administration (FDA) has appr...
Supira Medical has announced the appointment of Azeem Latib (Montefiore Heal...
This advertorial is sponsored by Boston Scientific
Today there are more than ...
Results from the PADN-5 study, investigating the efficacy and safety of pulm...
Saranas has announced that it has reached the midpoint for enrolment in SAFE-MCS...
A prospective observational study had found that, in asymptomatic persons, s...
Procyrion, a medical device company which aims to improve outcomes...
Abbott has today announced new data that found monitoring patients...
MedAlliance has announced enrolment of over 1,000 patients in its SELUTION DeNov...
Immediate, complete revascularisation with percutaneous coronary interventio...
Stereotaxis has announced the opening of a new robotic electrophysiology pro...
A total of £10 million has been awarded to the Medicines and Healthcare products...
Merit Medical has announced the expansion of itsSwiftNinja steerable microcathet...
Angiographic and clinical data from the BIOMAG-I clinical study, presented a...
HeartBeam, a cardiac technology company that has developed the three-dimensional...
Vivasure Medical has announced that the US Food and Drug Administration (FDA) ha...
LivaNova has announced the receipt of US Food and Drug Administration (FDA) 510(...
Assessing myocardial viability does not aid the selection of patients who wi...
February’s trending topics included a look at the past, present and future of tr...
A new trial of endovascular ultrasound-based renal denervation technology ha...
Edwards Lifesciences has highlighted new data examining mortality rates and ...
The European Union’s Council of Ministers has today adopted a resolution to exte...
Data from a new prespecified analysis of the phase III VOYAGER PAD clinical ...
Results of the Pulsed AF Pivotal trial, investigating pulsed field ablation ...
The largest randomised controlled trial to date to compare minimally invasiv...
Neovasc has announced that its shareholders have approved the previously-ann...
Use of intravascular imaging guidance for percutaneous coronary intervention (PC...
Large bore mechanical thrombectomy with the FlowTriever system (Inari Medica...
Final, five-year clinical outcomes from the COAPT trial, evaluating transcat...
Three-year results from the Evolut Low Risk trial have shown “durable” benef...
Hotly-anticipated results of the randomised TRILUMINATE pivotal trial, prese...
One-year insights from the bRIGHT registry, detailing real-world results of...
Researchers have detailed a new preclinical model for non-ST elevation myocardia...
Women have been found to have significantly higher risk of operative mortali...
SpectraWAVE has announced US Food and Drug Administration (FDA) 510(k) clearance...
Results from the PORTICO NG study of Abbott’s Navitor transcatheter aortic valve...
ReCor Medical and its parent company, Otsuka Medical Devices, recently annou...
Five-year bioprosthetic valve dysfunction data for Medtronic’s CoreValve and...
Results of a trial involving cell therapy in patients with chronic heart fai...
Results from the CONFORMAL early feasibility study (EFS), evaluating the use...
A model designed to predict surgical risk in the setting of adult congenital hea...
Medtronic has welcomed the publication of the consensus statement on renal dener...
Procyrion has announced the successful treatment of the first patients in the A ...
Disabilities were underreported in clinical trial data and commonly used as a ba...
Medtronic has announced the relaunch of its Harmony transcatheter pulmonary valv...
CVRx has announced the preliminary topline results of the BeAT-HF—Baroreflex act...
RapidAI announced it has received US Food and Drug Administration (FDA) 510(k) c...
The publication of a consensus statement from the European Society of Cardio...
Teleflex Incorporated has today announced key milestones in the release of two n...
A single-centre retrospective study of rehospitalisation after transcathete...
Xeltis has raised €32 million in a Series D2 equity fundraise, backed by a syndi...
NOTE: This video is ONLY available to watch in selected countries and geographie...
The American College of Cardiology (ACC), the American Heart Association (AHA) a...
Renal denervation represents another treatment option in patients with uncontrol...
As transcatheter aortic valve implantation (TAVI) moves beyond its 20-year ...
Sleeping an inconsistent number of hours each night and falling asleep at di...
Attendees of the 2023 Joint Interventional Meeting (JIM, 9–11 February, Milan, I...
SIS Medical AG has announced the launch of its OPN NC percutaneous transluminal ...
GE HealthCare has signed an agreement to acquire Caption Health, a developer...
Abbott and Cardiovascular Systems (CSI) have announced a definitive agreement fo...
A retrospective cohort study has found the likelihood of receiving percutane...
In the opening month of 2023, Cardiovascular News’ most read stories include sex...
This advertorial is sponsored by Cardionovum
“Everything started with bal...
A randomised study led by Greater Manchester Mental Health NHS Foundation Tr...
In this issue:
Medicare study reopens guideline debate around surgery and P...
In this issue:
Medicare study reopens guideline debate around surgery and P...
This advertorial is sponsored by iVascular
A new coronary scoring balloon...
Performance improvement company Biome Analytics has announced the publication of...
TruLeaf Medical is to conduct a first-in-human clinical trial of a “two-stag...
Percutaneous coronary intervention (PCI) without on-site surgical support is as ...
From cutting-edge aortic interventions to consensus on revascularisation strateg...
This advertorial is sponsored by B. Braun Melsungen AG
The modern field o...
AtriCure has announced that the first patient was treated in the LeAAPS clinical...
Trials in coronary imaging, transcatheter tricuspid valve interventions, tra...
Little progress has been made over the last decade in improving gender balance i...
Interventional cardiology is a rapidly evolving field, offering the opportunity ...
An analysis of data from more than 100,000 patients with multivessel coronar...
The first US patient has been enrolled at Medstar Washington Hospital Center (Wa...
BioVentrix, a privately held medical device company focused on the development o...
A group of engineers and physicians have created a wearable ultrasonic devic...
Transcatheter treatment options for aortic regurgitation (AR) bring a new, ...
A study conducted by Michigan Medicine (Ann Arbor, USA) researchers suggests tha...
A new risk assessment tool has been produced to provide a comprehensive meth...
Pie Medical Imaging has announced the enrolment of the 500th patient in the FAST...
Zoll has announced that the first patient has been enrolled in the REAL SSO2 pos...
The largest dedicated registry on mitral transcatheter edge-to-edge repair (...
Shockwave Medical has entered into a definitive agreement to acquire Neovasc...
The US Food and Drug Administration (FDA) has approved the Navitor (Abbott) tran...
Research evaluating the effects of high bleeding risk (HBR) and complex percutan...
Pie Medical Imaging has launched a new version of its echocardiography software ...
Viz.ai has announced the launch of Viz Vascular Suite—artificial intelligenc...
The UK’s National Institute for Health and Care Excellence (NICE) has published ...
HVR Cardio has closed on a €10.7 million series B round of financing. The Se...
Patients with depression were 10–20% less likely to adhere to guideline-directed...
Closer ties between cardiologists, cardiac surgeons and vascular surgeons will b...
Selution SLR, MedAlliance’s novel sirolimus-eluting balloon, has received condit...
A preclinical study demonstrating key features of the foam-based left atrial...
Cardiac Dimensions has closed a US$35 million Series D financing round. The ...
AVS has announced that it raised US$20 million in Series B financing, which the ...
Which stories, features and interviews captured the attention of the cardiovascu...
The Society for Cardiovascular Angiography & Interventions (SCAI) has announ...
Transcatheter tricuspid valve intervention is associated with similar outcom...
ReCor Medical and its parent company Otsuka Medical Devices have announced t...
Anthos Therapeutics has announced that it has enrolled the first patient in ...
Johnson & Johnson has today announced it has completed its acquisition of Ab...
Using machine learning and clinical data from electronic health records, researc...
Researchers have developed ‘stem cell plasters’ which it is hoped will revol...
The first two patients have been enrolled in the Impella ECP pivotal trial, ...
CytoSorbents Corporation has received the recommendation from the independen...
Pi-Cardia has announced that the first patient in the USA has been successfully ...
The current model for randomised clinical trials must be redesigned for the mode...
A first-in-human trial using a purpose-built device to provide direct wire pacin...
Corindus has been rebranded to Siemens Healthineers Endovascular Robotics an...
In a recent study which revealed higher readmission and mortality rates amon...
Europe’s health commissioner, Stella Kyriakides, has announced that proposal...
AstraZeneca has today announced that the Medicines and Healthcare products Regul...
TRiCares has announce the second closing and completion of its Series C financin...
Corvia Medical has announced that the first patient has been randomised in R...
A new method for determining whether patients with heart disease need corona...
The European Society of Cardiology (ESC) has urged European Union (EU) health mi...
The addition of an annular sealing skirt, among other design changes in the ...
One-year results from the TRISCEND study, investigating the Evoque (Edwards ...
This advertorial is sponsored by Medtronic
Durability, reliability, accur...
The Swiss Federal Assembly has voted in favour of accepting medical devices with...
Otsuka Medical Devices and ReCor Medical, a subsidiary of Otsuka, ...
Anteris Technologies has announced that the US Food and Drug Administration (FDA...
inQB8 Medical Technologies, in partnership with Peijia Medical, has announce...
Nyra Medical has announced the closing of a US$20 million Series A financing...
The first implant procedure using the Impella RP Flex (Abiomed) percutaneous pum...
A retrospective analysis of data collected from the Blue Cross Blue Shield of Mi...
Data presented at an innovation session at the 2022 Structural and Coronary Inte...
A pioneer of one of the first regional ST-segment elevation myocardial infarctio...
Carmat has announced the resumption of commercial implants of its Aeson total ar...
CroíValve has announced the successful first in human implants of its Duo tr...
In this issue:
Latest evidence from key renal denervation trials
REVIVED...
In this issue:
Latest evidence from key renal denervation trials
REVIVED...
Extended follow-up of the ISCHEMIA-EXTEND trial has shown no difference in r...
Viz.ai has announced a partnership with Illuminate, a developer of proprietary n...
Bivalirudin is a safer and more effective anticoagulant than heparin for treatin...
Soundbite Medical Solutions announced that it has entered into an exclusive lic...
CVRx—the developer of the “world’s first” US Food and Drug Administration (FDA)-...
Mentice has announced that Siemens Healthineers China is showcasing the remote c...
Patients at high risk for acute kidney injury (AKI), the most common complicatio...
WL Gore & Associates has announced that it is initiating the RELIEF clin...
Neovasc has announced that the Centers for Medicare and Medicaid Services (CMS) ...
ReCor Medical and its parent company, Otsuka Medical Devices, announced cons...
Medtronic has announced the six-month results from the full cohort of the SP...
The first results from the BEST-CLI randomised controlled trial (RCT) of 1,8...
The American College of Cardiology (ACC) and American Heart Association (AHA) ha...
Johnson & Johnson is to acquire Abiomed, it was announced today, after the t...
Abiomed has announced that Impella RP Flex with SmartAssist has received US Food...
Transit Scientific has announced that the XO RX 2.2Fr and XO RX 3.8Fr platform h...
The application of new technologies and techniques to treat challenging and ...
This session really reminds clinicians that the answer is not always an intervention in 100% of patients.
Heinz Jakob (Essen, Germany) and Tilo Kölbel (Hamburg, Germany) offer their ...
Carmat, developer of the Aeson total artificial heart, has announced that it...
Abiomed has announced the US Food and Drug Administration (FDA) has accepted...
OpSens Medical has announced the successful completion of the first cases in a c...
Bruce Ovbiagele, associate dean and professor of neurology at the University...
Selution SLR, MedAlliance’s novel sirolimus-eluting balloon, has received US Foo...
In patients undergoing coronary artery bypass graft (CABG) surgery, the addi...
Researchers are to investigate the safety and efficacy of performing left at...
AccurKardia, a software company that provides clinical-grade, device agnostic, a...
HeartFlow has received US Food and Drug Administration (FDA) 510(k) clearanc...
MedAlliance is to be acquired by Cordis, it was announced today, after the two c...
In a large, population-based study of patients with atrial fibrillation (AF) and...
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Ab...
An analysis of data from the Swedish Coronary Angiography and Angioplasty Re...
An analysis of more than 2,000 patients from a large US real-world database ...
The Uppsala Clinical Research Center (UCR) and the European Cardiovascular R...
The developers of a cannula for minimally-invasive central aortic perfusion—...
CathWorks has announced approval of the fourth generation CathWorks FFRangio...
A global research initiative will compare coronary artery bypass graft surge...
The chance of a patient surviving after an acute type A aortic dissect...
Clinical trials in cardiothoracic surgery must ensure that sufficient number...
Ajay Kirtane (Columbia University Irving Medical Center New York-Presbyteria...
Results of the FLASH registry demonstrate the “excellent safety profile” of ...
Three-year outcomes from the SMART-CHOICE trial have shown that P2Y12 inhibitor ...
ABILITY DIABETES-GLOBAL, a randomised controlled head-to-head trial comparing sa...
Puzzle Medical Devices was announced as the winner of the Shark Tank innovation ...
The use of rivaroxaban for seven days after a transradial coronary procedure...
Results of a new per-protocol analysis of the ST-segment Elevation Myocardia...
OpSens has announced that Philippe Genereux (Morristown Medical Center, Morristo...
Biotronik has announced the presentation of new full-cohort two-year BIOSOLV...
Medtronic has received Food and Drug Administration (FDA) approval for the treat...
JenaValve Technology has announced the successful completion of patient enrolmen...
Analysis of data from the Society of Thoracic Surgeons/American College of C...
Results from a multicentre randomised trial comparing ultrasound with fluoro...
Medtronic has announced the expanded US market release of its newest-generation,...
Shockwave Medical has initiated a prospective coronary intervention study consis...
Advanced NanoTherapies has been granted US Food and Drug Administration (FDA...
Long-term follow-up of patients with non-valvular atrial fibrillation (AF) r...
Findings from the RADIANCE II randomised pivotal trial, presented at the 202...
The major contribution of Valentin Fuster (Mount Sinai Health System, New Yo...
The first randomised trial to compare two transcatheter edge-to-edge repair ...
Among patients undergoing transfemoral transcatheter aortic valve implantati...
OpSens has received 510(k) regulatory clearance from the US Food & Drug Admi...
The 2022 Transcatheter Cardiovascular Therapeutics (TCT, 16–19 September, Bo...
Abiomed has announced two approvals from the US Food and Drug Administration (FD...
Edwards Lifesciences has announced that its Pascal Precision transcatheter valve...
Teleflex has announced that Magnus Settergren, associate professor at the Karoli...
Cardiac Implants has announced the successful initial deployment of its annulopl...
Concept Medical has announced the successful completion of the TRANSFORM 1 R...
A budget impact analysis comparing transcatheter aortic valve implantation (...
Haemonetics Corporation has received CE mark certification for its Vascade v...
Edwards Lifesciences has announced the launch of the Sapien 3 Ultra Resilia valv...
Abbott has announced three-year data for its Amplatzer Piccolo occluder for the ...
Analysis of the global make-up of the four largest global societies for cardioth...
Results of an analysis of Aktiia’s cuffless blood pressure (BP) monitoring syste...
Zoll Medical has announced that the first patient has been enrolled in the AMIHO...
Abbott has announced the European launch of its Amplatzer Talisman patent forame...
AtriAN Medical has announced that it has completed enrolment of a second study u...
As a proponent of minimally invasive cardiac surgery and transcatheter technique...
The most read stories from across Cardiovascular News in August 2022 include hig...
Viz.ai has received US Food and Drug Administration (FDA) 510(k) clearance for a...
Royal Philips has announced that Baptist Health’s Miami Cardiac & Vascular I...
Boston Scientific has received US Food and Drug Administration (FDA) approva...
Andrew Wigham (Oxford, UK) and Rick De Graaf (Friedrichshafen, Germany) dis...
Cardionovum has announced the enrolment of the first patient in the internat...
JenaValve Technology has announced that it has completed the initial closing of ...
Researchers have developed a risk score to predict mortality for patients wi...
Abbott has announced the release of late-breaking showing that its HeartMate...
Transradial access for percutaneous coronary procedures is associated with l...
Fifteen-month results from the MASTER DAPT trial have shown that the preserv...
In patients with advanced chronic kidney disease (CKD) and chronic coronary ...
Selection of non-infarct related artery (IRA) lesions for intervention using...
Late-breaking research presented at the European Society of Cardiology (ESC)...
Among high-risk patients undergoing percutaneous coronary intervention (PCI)...
Results of one of the first and only randomised, blinded trials to assess th...
Percutaneous coronary intervention (PCI) does not reduce all-cause mortality...
Use of a ‘polypill’ after myocardial infarction (MI)—an all-in-one pill cont...
ŌNŌCOR has announced in a company press release that the ŌNŌ endovascular retrie...
The timing of dosing of antihypertensive medication—whether it is taken in t...
The Cardiovascular Research Foundation (CRF) and Fogarty Innovation have ann...
Medtronic has announced the launch of its latest generation drug-eluting coronar...
In this issue:
Call for action over age and gender profile of global cardio...
In this issue:
Call for action over age and gender profile of global cardio...
Miracor Medical has announced the approval of an investigational device exem...
Pi-Cardia has announced a successful first-in-human treatment of the mitral valv...
Edwards Lifesciences has announced that the company's Pascal Precision trans...
Abiomed has announced the results of the Restore EF study, demonstrating that I...
CX Aortic Vienna returns in October for its third edition (24–26 October, Digita...
The American Heart Association (Association) and the Cardiovascular Research Fou...
Ongoing clinical trials looking at transcatheter aortic valve implantation (...
The most read stories from across Cardiovascular News in July 2022 include refle...
Projected rates of cardiovascular risk factors and disease will increase signifi...
Thubrikar Aortic Valve has announced successful 30-day outcomes in the first two...
Cardiac surgeons from North America, Europe and Latin America are among the sign...
A project to develop genetic therapies to effectively cure cardiomyopathy ha...
iVascular has announced the release of three-year observational data concerning ...
Neovasc has announced that the US Food and Drug Administration (FDA) has app...
Centese has announced the publication of the first peer-reviewed clinical study ...
Pi-Cardia has received Investigational Device Exemption (IDE) approval from the ...
ReCor Medical and Otsuka Medical Devices have announced that the RADIANCE II US ...
Incentives for the enrolment of patients from socieconomically disadvantaged...
Cathbot—a joint venture between Robocath and MicroPort—has enrolled the last pat...
Preventing coronary obstruction after transcatheter aortic valve implantatio...
A research project at the University of Leeds (Leeds, UK) aiming to find an ...
Ancora Heart has announced that the US Food and Drug Administration (FDA) ha...
Intratech Medical has announced the successful enrolment of two patients in a mu...
The VenusP-Valve (Venus Medtech) transcatheter pulmonic valve replacement (T...
Medtronic today announced it has entered into a strategic partnership agreement ...
Patients identified by nuclear stress testing as having severe stress-induce...
Transcatheter aortic valve implantation (TAVI) will continue to spread acro...
Echocardiographers may be at significantly greater risk of exposure to radiation...
The Cardiovascular Research Foundation (CRF) and Fogarty Innovation have announc...
A subgroup analysis of the BIO-RESORT trial has shown a “trend towards bette...
HeartBeam is expanding the available patient population for its emergency depart...
The most read stories from across Cardiovascular News in June 2022 include highl...
Suzanne Baron and Ki Park detail some of the barriers facing women in the fi...
Advanced NanoTherapies has closed a US$7.2 million Series A equity financing...
Results from the first commercial implants of the Trilogy transcatheter aort...
Teleflex has announced the first patient enrolment in a clinical study that ...
People who develop an arrhythmia after surgery have an increased risk of subsequ...
Acutus Medical has announced the commercial launch of an expanded suite of l...
A retrospective study from Kubkin Choi and researchers from Mayo Clinic (Rochest...
SoniVie recently announced that on 5 May 2022 the US Food and Drug Administratio...
Conformal Medical has announced the launch of the CONFORM pivotal trial with...
The National Institute for Health and Care Excellence (NICE) has recommended...
Dual antiplatelet therapy (DAPT) after left atrial appendage occlusion (LAAO...
Transcatheter aortic valve implantation (TAVI) with the Acurate neo2 (Boston...
Analysis of the EXPAND registry, looking at one-year outcomes of MitraClip t...
Data from the first report on patients with a pacemaker lead across the tric...
AtriCure has announced that the first patient has been treated in the HEAL-IST t...
The potential to utilise artificial intelligence (AI) or machine learning in c...
This advertorial is sponsored by Adept Medical.
Outlining Adept Medical’s pro...
A retrospective review of more than 24,000 patients who underwent an electrocard...
Filterlex Medical has announced results from a first-in-human (FIH) study de...
A study has revealed the “global collateral damage” caused by the disruption to ...
A new consensus statement—in development from the European Society of Cardi...
“At the moment, tricuspid is the valve where most things are happening,” sa...
Transcatheter aortic valve implantation (TAVI) was found to be non-inferior ...
The use of distal radial artery access for percutaneous coronary interventio...
Concurrent tricuspid valve surgery and left ventricular assist device (LVAD)...
Robotic-assisted percutaneous coronary intervention (PCI) has the potential...
New data confirming one-year outcomes with coronary intravascular lithotrips...
Sunil Rao (Duke University Health System, Durham, USA) has assumed the offic...
Endotronix has announced data from the SIRONA 2 clinical trial evaluating sa...
Shockwave Medical and Genesis MedTech Group announced today that they have succe...
Adept Medical says it has responded to the call from interventional radiolog...
Transcatheter tricuspid valve repair potentially offers a “less risky” opti...
One-year outcomes of the CLASP TR study, investigating the use of the Pascal (Ed...
Matti Adam (Cologne, Germany) talks to Cardiovascular News about the evolut...
Use of the cusp overlap technique for the deployment of devices in transcath...
Results of the 20-patient, first-in-human clinical study supporting the safety a...
Patients in England with ST-elevation myocardial infarction (STEMI) had an a...
“Renal denervation has travelled a very storied path over the last 10–15 ye...
Analysis of data from a US-wide health system suggests that the volume of percut...
Biotronik has shared new data presented at EuroPCR 2022 (17–20 May, Paris, F...
New data on robotic-assisted percutaneous coronary intervention (PCI) have been ...
Vivasure Medical has announced the closing of the first tranche of €22 million (...
Analysis of the MASTER DAPT trial, presented as a late-breaking trial at EuroPCR...
Late-breaking trial data presented at EuroPCR 2022 (17–20 May, Paris, France...
Medtronic has announced that it has received US Food and Drug Administration (FD...
In this issue:
New data hint at positive performance of TAVI on structural ...
In this issue:
New data hint at positive performance of TAVI on structural ...
A US analysis comparing trends in transcatheter and surgical mitral valve repair...
Abbott has announced a new partnership with Women as One to launch a new program...
Vijay Kunadian (Newcastle University and Newcastle upon Tyne Hospital NHS Founda...
This advertorial is sponsored by Siemens Healthineers
In the modern cath lab,...
This advertorial is sponsored by Medtronic
Due to the growth of transcath...
The most read stories from across Cardiovascular News in April 2022 include high...
At the 2022 Charing Cross (CX) International Symposium (26–28 April, London,...
This educational supplement, sponsored by Medtronic, explores the science underp...
In the history of transcatheter aortic valve implantation (TAVI), 16 April 2002 ...
OpSens has announced that it has received Health Canada approval for the SavvyWi...
Biosensors International Group has announced both the Japanese Pharmaceutica...
Medtronic has announced the first patient enrolment in the EXPAND TAVR II pi...
Medtronic has announced that Laura Mauri has been appointed as the company’s chi...
The Society for Cardiovascular Angiography & Interventions (SCAI) has releas...
Translumina has announced the launch of Vivo Isar, its latest generation dual dr...
The pandemic saw a boom in the use of remote technologies and telehealth for...
Corindus, a Siemens Healthineers company, announced today the opening of its new...
Transit Scientific has announced US Food and Drug Administration (FDA) clear...
Quest International and CathWorks have announced a strategic partnership. Qu...
Viz.ai has raised a US$100 million funding round at a US$1.2 billion valuation, ...
Venus Medtech's transcatheter pulmonic valve replacement (TPVR) system—Venus...
CeloNova BioSciences has announced the strategic decision to focus its core ...
Patients treated with edoxaban for six months after a transcatheter aortic v...
The most read stories from across Cardiovascular News in March 2022 include a we...
FEops has announced that it received authorisation from the US Food and Drug...
Abiomed has announced that the first patient in Japan has been treated succe...
Biosensors International has announced the enrolment of the first patient in the...
Patients who received a transcatheter supra-annular self-expanding heart valve h...
Latest results from the North American COVID-19 STEMI (NACMI) registry repor...
A head-to-head comparison of fractional flow reserve (FFR) and intravascular ult...
Long-term data from the first 80 patients in the SPYRAL HTN-ON MED trial have be...
Patients with tricuspid regurgitation (TR) who received a Pascal transcatheter v...
Corvia Medical has announced publication of analyses from its global, phase ...
Percutaneous coronary intervention (PCI) guided by fractional flow reserve (...
East End Medical has announced the first commercial use of its SafeCross tra...
Royal Philips is launching an echocardiography image analysis and reporting solu...
The Society for Cardiovascular Angiography & Interventions (SCAI) has releas...
Edwards Lifesciences has announced it received approval from the US Food and Dru...
Shockwave Medical’s C2 coronary intravascular lithotripsy (IVL) catheter has rec...
Miracor Medical has announced the first patient enrolled in the PICSO-AMI-V ...
Investigators have completed enrolment in the RADIANCE-II pivotal trial of the P...
Carmat, designer and developer of an advanced total artificial heart, has is...
Researchers have detailed the use of an artificial intelligence-enabled tool...
Cardiawave has announced the success of its first-in-human I (FIH I) safety and ...
A consensus document outlining design principles and outcome definitions for dev...
Four radial cases using the PH Band System (Medical Ingenuities)—a novel med...
Venus Medtech has appointed Shakeel Osman as senior vice president of sales Euro...
Women are less likely to receive lifesaving treatment for cardiogenic shock than...
Only 76% of heart attack patients with dyspnoea or fatigue as their main symptom...
Nick West, chief medical officer and divisional vice president of Global Med...
Xeltis has announced promising initial outcomes from two key vascular trials inv...
The American College of Cardiology (ACC) has issued an expert consensus decision...
Cardiovascular Systems—CSI—has announced the first in-human experience with Prop...
Vivasure Medical has announced today that the first patient was treated in a...
A new strategy using telehealth to monitor blood pressure at home for severa...
“When I was one year old, my father died in the war between Israel and Egypt...
Big Sky Biomedical has appointed Ryan Egeland as managing director.
“Big ...
Medtronic has announced that it has entered into a contract with Vizient to ...
The most read stories from across Cardiovascular News in February 2022 include t...
Two-year findings from the Low-risk TAVI (LRT) Trial, assessing clinical out...
A novel transcatheter system designed for transfemoral mitral valve repair—t...
Final findings from the COBRA-REDUCE randomised trial assessing 14-day dual ...
Four-year data from the LRT—Low Risk TAVR—trial show that transcatheter aort...
Levels of high-sensitivity troponin I after cardiac surgery that were associated...
Biotronik has announced final enrolment in the BIOMAG-I clinical trial by Mi...
Results from a new analysis assessing real-world outcomes with the Watchman ...
Women remain underrepresented in leading cardiovascular clinical trials, cor...
Results from the first animal study of the Tria transcatheter aortic valve (...
Final five-year results from the BIOFLOW-V trial, presented during a late-br...
Charing Cross (CX) chair Roger Greenhalgh welcomes the vascular community to thi...
Wearable technology and digital health specialist Activinsights has announced a ...
Patients with both a high lipoprotein(a) and high coronary artery calcium sc...
Anticipation is building for the Charing Cross International Symposium 2022 ...
Teleflex has announced that the US Food and Drug Administration (FDA) has cleare...
Historically, catheter ablation has been reserved for atrial fibrillation (A...
Valve-in-valve transcatheter aortic valve implantation (TAVI) was associated...
Siemens Healthineers has announced the launch of Artis icono biplane—an angiogra...
The “Ross procedure” may be a more favourable option for aortic valve replac...
Abbott has announced that the US Food and Drug Administration (FDA) has approved...
A 10-year study monitoring patients receiving “on-pump” or “off-pump” coronary a...
Consultation by a heart team led to an observed benefit in objective patient out...
Researchers have developed a novel method of measuring growth of thoracic aortic...
Cardiologist and researcher Robert Califf has been confirmed as the commissi...
Robotic systems have the potential to fundamentally change the way care is deliv...
The donation of new 3D printing technology to the Visible Heart Laboratories...
Elixir Medical has announced completion of enrolment in the BIOADAPTOR rando...
Boston Scientific has announced the close of its acquisition of Baylis Medic...
MedHub has announced the completion of a funding round worth US$1 million in new...
The Supreme healing-targeted drug-eluting stent (Sinomed) is effective and s...
Peter Haworth (Portsmouth Hospitals University NHS Trust, Portsmouth, UK) docume...
HeartFlow has announced that it and Longview Acquisition Corporation have mutual...
Lung cancer patients with higher amounts of coronary artery calcium have an incr...
The use of intravascular ultrasound (IVUS) guidance for implantation of drug-elu...
The most read stories from across Cardiovascular News in January 2022 include co...
Acarix has submitted a breakthrough designation request for its technology for h...
The John Radcliffe Hospital—part of Oxford University Hospitals NHS Foundati...
Royal Philips has announced an update to its handheld ultrasound platform—Lumify...
Atheart Medical has announced that it has received US Food and Drug Administ...
The placement of an interarterial shunt device—the Corvia atrial shunt (Corv...
Biosensors has announced the enrolment of the first patient in the RISE SC study...
BioCardia has announced that the US Food and Drug Administration (FDA) has grant...
CroíValve has raised a Series A round to fund a feasibility clinical study w...
Black adults born in the USA had a higher rate of death from cardiovascular ...
The Society for Cardiovascular Angiography & Interventions (SCAI) has an...
Abbott has released a second round of insights from its Beyond Intervention ...
This advertorial is sponsored by Shockwave Medical.
The latest data from the ...
This advertorial is sponsored by Medtronic.
Evolut PRO+ is the latest generat...
Born in India and raised in Pittsburgh, USA, Susheel Kodali now practices in...
In this issue:
Coronary revascularisation guidelines spark debate
New d...
In this issue:
Coronary revascularisation guidelines spark debate
New d...
Insights from what was described as the “largest and most comprehensive” ana...
Artivion has announced the publication of PROACT clinical trial results in The A...
The Society for Cardiovascular Angiography and Interventions (SCAI) has rele...
Cardiothoracic surgeon John H Calhoon from The University of Texas Health Sc...
Patients with mitral valve disease who live in disadvantaged communities are...
InnovHeart, developer of novel transcatheter mitral valve replacement (TMVR) sys...
Organisers of the Joint Interventional Meeting (JIM) have announced that the 202...
The first patient has been enrolled in the TRANSFORM II randomised controlle...
Radiation exposure during percutaneous coronary intervention (PCI) has fallen “c...
Researchers have warned that the number of people suffering from aortic valve st...
The US Food and Drug Administration (FDA) has issued two final guidances providi...
Congenita has been named a recipient of the MedTech NAVIGATOR Innovation Grant S...
A review evaluating the results of thoracic endovascular aortic repair (TEVA...
New clinical practice guidelines have been published today, and are intended to ...
CytoSorbents has called attention to a new publication which reports on the use ...
Cardiovascular Systems (CSI) and OrbusNeich Medical Company have announced US Fo...
WL Gore & Associates has announced that its Cardioform Septal Occluder h...
In a joint programme between the Society of Thoracic Surgeons (STS) and the ...
A new study reports that watching TV for four hours a day or more is associated ...
Royal Philips today announced physicians will now have access to advanced ne...
New guidelines from the American College of Cardiology (ACC) and the American He...
Cardiovascular Systems recently announced that it has made significant progress ...
A propensity score-matched analysis of the early outcomes of transcatheter aorti...
A 57-year-old patient with terminal heart disease received a successful transpla...
The American Association for Thoracic Surgery (AATS) and The Society of Thoracic...
The Society of Thoracic Surgeons (STS) has moved its 2022 annual meeting from an...
Terumo Medical Corporation has welcomed the publication of updated guidelines fr...
Robocath has announced the conclusion of its R-Evolution clinical study in Europ...
Regulators in three countries have granted approvals to Impella surgical product...
Medtronic has announced that the National Medical Products Administration (N...
The most read stories from December 2021 include analysis of the CHEETAH study a...
Neovasc has announced enrolment of the first patient in the COSIRA-II clinical t...
Endotronix has announced that the US Food and Drug Administration (FDA) has ...
Biomodex and the Montreal Heart Institute (MHI, Montreal, Canada) are partne...
Vesalio recently announced the start of enrolment in its NATURE study using enVa...
Royal Philips has announced US Food and Drug Administration (FDA) de novo cl...
Foldax has announced publication of the first clinical results for its Tria ...
Edwards Lifesciences has received approval from the US Food and Drug Adminis...
Doctors at St David's Medical Center in Austin, USA recently implanted a new neu...
Many patients undergoing cardiac surgery may be able to safely and effectively c...
FAST BioMedical has announced the publication of additional results from the EMP...
Thubrikar Aortic Valve has received approval from a Competent Authority in Polan...
Ultromics has announced the publication of a study assessing its EchoGo plat...
HeartFlow has announced it has submitted a 510(k) premarket application to the U...
Results of the CHEETAH clinical study highlight the potential role of mechan...
Svelte Medical Systems has received US Food and Drug Administration (FDA) approv...
Opsens has filed a 510(k) submission with the US Food & Drug Administration ...
The Society of Thoracic Surgeons (STS) has appointed Joanna Chikwe (chair of the...
The likelihood of patients with suspected or known coronary artery disease dying...
Huge strides have been made in preventing contrast-associated acute kidney i...
New guidelines for coronary artery revascularisation recommend that treatment de...
A team led by investigators at Massachusetts General Hospital (MGH) in Boston, U...
RSIP Vision has announced a new coronary artery modelling technology, which enab...
Royal Philips has announced an expansion of its ultrasound portfolio with ne...
Foldax has announced that the Drugs Controller General of India (DCGI), India’s ...
Venus Medtech has announced its acquisition of Cardiovalve, a transcatheter mitr...
SyMap Medical has announced the completion of a financing round which will b...
Restore Medical has announced preliminary results of the first-in-human clinical...
The first analysis of findings from the bRIGHT registry, detailing rea...
One in 10 junior doctors training to be cardiologists in the UK say they have be...
Interim results from the REVERSE-IT trial of bentracimab (PhaseBio Pharmaceu...
Featuring stories from the Transcatheter Cardiovascular Therapeutics annual meet...
A novel artificial intelligence (AI) algorithm that identifies a cardiac dysfunc...
Soundbite Medical Solutions has announced that the US Patent and Trademark Offic...
Robocath has announced the successful completion of what it has described as the...
Findings of the CHOICE MI registry show that transcatheter mitral valve impl...
Findings from an on-treatment major bleeding analysis from the ENVISAGE TAVI...
Mirvat Alasnag is the Gulf region’s first female interventional cardiologist. Cu...
Cardiovascular Systems has initiated a voluntary recall of unused Wirion embolic...
Two-year findings of a post-hoc study from the GALILEO trial, investigating ...
First clinical results of transcatheter aortic valve implantation (TAVI) usi...
The first 30-day results following the implantation of the NeoChord NeXuS tr...
Opsens has announced the successful treatment of 20 patients leading to the comp...
The Minneapolis Heart Institute Foundation (MHIF; Minneapolis, USA) has announce...
The first patients have been enrolled in the FAST III trial at the Erasmus Unive...
European Society of Cardiology (ESC) guidance for the diagnosis and management o...
New guidance on the diagnosis and presentation of cardiogenic shock aims to ...
A meta-analysis comparing percutaneous coronary intervention (PCI) using a d...
Nonagenarians should not be refused transcatheter aortic valve implantation (TAV...
An updated risk score to predict possible contrast-associated acute kidney i...
Use of a novel, venous external support device (VEST, Vascular Graft Solutio...
HeartVista has received US Food and Drug Administration (FDA) 510(k) clearance t...
Coronary artery bypass graft sugery (CABG) between two and three days after tica...
Asymptomatic patients with severe aortic stenosis (AS) may benefit from early ao...
Ahead of the American Heart Association’s 2021 annual scientific sessions (AHA 2...
This advertorial is sponsored by iVascular
Treatment of a chronic total occlu...
Early data presented at the Transcatheter Cardiovascular Therapeutics annual...
Caption Health and Ultromics have announced a strategic partnership to accelerat...
Abbott has released new research from its Beyond Intervention initiative, a mult...
SIS Medical AG has appointed Ron Waksman, associate director Division of Car...
Transcatheter aortic valve implantation (TAVI) pioneer and principal investigato...
Cardiovascular Systems has announced the start of enrolment in a first in-human ...
Patients who went into cardiac arrest in the cardiac cath lab were more likely t...
CoreMedic has announced the publication of two-year follow-up results from the f...
Medtronic has announced its ambition to achieve net zero carbon emissions by fis...
Data from the BIOSOLVE-IV trial, presented at the Transcatheter Cardiovascul...
Six-month results from the TRISCEND study of the Evoque (Edwards Lifescience...
Early data for the self-expanding Intrepid (Medtronic) transcatheter mitral ...
Findings of the SWISS-APERO trial, presented at the Transcatheter Cardiovasc...
Patients receiving antiplatelet therapy following percutaneous coronary inte...
The final results of the PROTECT III and Restore EF prospective studies demo...
Left atrial appendage occlusion (LAAC) remains non-inferior to non vitamin-K...
Five-year clinical and echocardiographic outcome data from the SURTAVI rando...
Results from the largest randomised trial to date comparing different closur...
An economic analysis of data from the PARTNER 3 randomised trial, comparing ...
Penumbra has announced that the CHEETAH clinical study of its Indigo system ...
One-year outcomes from the Disrupt CAD III clinical study of Shockwave intravasc...
Results from SUGAR, a randomised controlled, multicentre trial conducted exclusi...
Randomised placebo-controlled trials show consistently that renal denervation pr...
Six-month outcomes from the randomised RADIANCE-HTN TRIO trial, comparing en...
Lesion selection for percutaneous coronary intervention (PCI) using the non-inva...
Percutaneous coronary intervention (PCI) guided by fractional flow reserve (...
Medtronic has announced findings from a new study of patient preferences for the...
In this issue:
MASTER DAPT game changing for short-duration dual antiplate...
In this issue:
MASTER DAPT game changing for short-duration dual antiplate...
Royal Philips has previewed updates in its product portfolio and new data due to...
Procyrion has announced the presentation of studies at the Transcatheter Cardiov...
Hypertension health-tech firm Aktiia has announced a US$17.5 million Series ...
ReValve Solutions has announced that it has successfully completed the first-in-...
Results from two studies of the Impella heart pump device will be presented at t...
This educational supplement, sponsored by Medtronic, explores the latest evidenc...
Joint clinical practice guidelines have been issued by the American Heart Associ...
Speakers at the European Society of Cardio-Thoracic Surgery annual meeting (EACT...
The longest available real-world follow-up data of transcatheter mitral ...
Teleflex announced the completion of patient enrolment in a clinical study evalu...
Patients who survive an aortic dissection often fail to receive comprehens...
The Cardiovascular Research Foundation (CRF) has announced that the digital comp...
Sinomed has announced that the PIONEER III clinical trial results for its HT...
Cardiac CT angiography (CTA) derived left atrium emptying fraction (LAEF) im...
JenaValve Technology has announced the first commercial implants with the Trilog...
HeartFlow has announced the commencement of the REVEALPLAQUE trial to evaluate t...
The expansion of transcatheter aortic valve implantation (TAVI) in the USA has p...
Ethnic and racial minority cardiologists report career satisfaction but face pro...
“We are at the beginning of a type A dissection revolution,” Joseph E Bavari...
The underrepresentation of women in clinical coronary revascularisation tria...
OpSens has announced the commencement of the human clinical study utilising the ...
Building and maintaining expertise in both open and endovascular surgical te...
ReCor Medical has announced that its Paradise ultrasound renal denervation syste...
Baylis Medical Company has reached an agreement to sell its cardiology business ...
In a session on “Reduction of radiation challenges” at CX Aortic Vienna 2021...
Bert van Meurs is the chief business leader for Image Guided Therapy within Roya...
A decisive vote at CX Aortic Vienna 2021 (5–7 October, broadcast) revealed t...
Results of a poll conducted at CX Aortic Vienna 2021 (5–7 October, broadcast...
A worldwide committee of 40 cross-specialty medical experts achieved the fir...
NeoChord has announced successful completion of the first-in-human procedure wit...
Top stories for September included more highlights from the European Society of ...
Royal Philips and Lankenau Heart Institute part of Main Line Health (Wynnewood, ...
